In NSCLC, researchers have shown that the level of TGF-β1 protein levels within tumor tissue is significantly associated with lymph node metastasis, advanced disease stages, and increased micro-vessel density, indicating its role in tumor angiogenesis and progression. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.